Skip to main content

FDA Approvals

FDA Approvals
Belinostat Approved for Peripheral T-Cell Lymphoma
Read More
FDA Approvals
Palonosetron Indicated for CINV Prevention in Pediatric Patients
Read More
FDA Approvals
Zykadia for Metastatic, ALK-Positive Lung Cancer
Read More
FDA Approvals
Ramucirumab First Drug for Advanced Stomach Cancer
Read More
FDA Approvals
Ofatumumab Approved for Patients with CLL
Read More
FDA Approvals
Ibrutinib Approved for CLL
Read More
FDA Approvals
First Drug Combination Approved for Unresectable or Metastatic Melanoma
Read More
FDA Approvals
Anti–PD-1 Antibodies for NSCLC and Renal Carcinoma
Caroline Helwick
Read More
FDA Approvals
Enthusiasm Sky High for Immunotherapy with Anti–PD-1 Agents in Cancer
Caroline Helwick
Read More
FDA Approvals
2014 Oncology Pipeline Looks Impressive
Caroline Helwick, Wayne Kuznar
Read More
Page 44 of 53
Results 431 - 440 of 522